Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

J App Pharm Sci. 2019; 9(7): 130-139


Nutritional and therapeutic benefits of medicinal plant Pithecellobium dulce (Fabaceae): A review

Selvakumar M, DInesh Kumar L, Velusamy A.




Abstract
Cited by 21 Articles

Pithecellobium dulce, an evergreen medium-sized, spiny tree, each part of the plant has vast nutritional values; stuffed with essential vitamins, amino acids and minerals. The fruits of P. dulce, widely used in Ayurvedic medicines and home remedies. The plant has also been a rich source of biologically active compounds such as tannin, olein and glycosides. Totally 38 active phytocompounds like quercetin, kaemferol, dulcitol were identified from the various parts of the plant. Notably, this plant has catechol type of tannins in bark. There are polyphenol classes of phytocompounds which have found to be hold potent an antivenom activity. Their fruits are rich source of phenols, flavonoids and saponins reported for their efficacy to treat diabetes, oxidative stress, and gastrointestinal disorders. The plant leaf and seed have an antibacterial, antifungal and adulticidal activities. Thus, the present review describes on exploiting the medicinal properties of P. dulce and its biomedicinal applications in therapeutic development.

Key words: Pithecellobium dulce, Legume, Nutrients, Phytochemicals, Therapeutic value






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.